May 15, 2024Open Access

Supplemental Table 3 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas

Key points are not available for this paper at this time.

Supplemental Table 3: Patient Survival and Mutation Characteristics

KI fragen

Bookmark

View Full Paper

Cite This Study

Desai et al. (Wed,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper